Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes

Cinnamoyl sucrose esters (CSEs) were evaluated as AGIs and their enzyme inhibition activity and potency were compared with gold standard acarbose. The inhibition activity of the CSEs against α-glucosidase and α-amylase depended on their structure including the number of the cinnamoyl moieties, their...

Full description

Bibliographic Details
Main Authors: Surabhi Devaraj, Yew Mun Yip, Parthasarathi Panda, Li Lin Ong, Pooi Wen Kathy Wong, Dawei Zhang, Zaher Judeh
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/2/469
_version_ 1797410372186013696
author Surabhi Devaraj
Yew Mun Yip
Parthasarathi Panda
Li Lin Ong
Pooi Wen Kathy Wong
Dawei Zhang
Zaher Judeh
author_facet Surabhi Devaraj
Yew Mun Yip
Parthasarathi Panda
Li Lin Ong
Pooi Wen Kathy Wong
Dawei Zhang
Zaher Judeh
author_sort Surabhi Devaraj
collection DOAJ
description Cinnamoyl sucrose esters (CSEs) were evaluated as AGIs and their enzyme inhibition activity and potency were compared with gold standard acarbose. The inhibition activity of the CSEs against α-glucosidase and α-amylase depended on their structure including the number of the cinnamoyl moieties, their position, and the presence or absence of the acetyl moieties. The inhibitory values of the CSEs <b>2</b>–<b>9</b> generally increases in the order of mono-cinnamoyl moieties < di-cinnamoyl ≤ tri-cinnamoyl < tetra-cinnamoyl. This trend was supported from both in vitro and in silico results. Both tetra-cinnamoyl CSEs <b>5</b> and <b>9</b> showed the highest α-glucosidase inhibitory activities of 77 ± 5%, 74 ± 9%, respectively, against acarbose at 27 ± 4%, and highest α-amylase inhibitory activities of 98 ± 2%, 99 ± 1%, respectively, against acarbose at 93 ± 2%. CSEs <b>3</b>, <b>4</b>, <b>6</b>, <b>7</b>, <b>8</b> showed desired higher inhibition of α-glucosidase than α-amylase suggesting potential for further development as AGIs with reduced side effects. Molecular docking studies on CSEs <b>5</b> and <b>9</b> attributed the high inhibition of these compounds to multiple π-π interactions and favorable projection of the cinnamoyl moieties (especially O-3 cinnamoyl) in the enzyme pockets. This work proposes CSEs as new AGIs with potentially reduced side effects.
first_indexed 2024-03-09T04:28:58Z
format Article
id doaj.art-a8202d9f2b0f44808ad40604e45c7446
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T04:28:58Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-a8202d9f2b0f44808ad40604e45c74462023-12-03T13:38:15ZengMDPI AGMolecules1420-30492021-01-0126246910.3390/molecules26020469Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of DiabetesSurabhi Devaraj0Yew Mun Yip1Parthasarathi Panda2Li Lin Ong3Pooi Wen Kathy Wong4Dawei Zhang5Zaher Judeh6School of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, N1.2–B1-14, Singapore 637459, SingaporeSchool of Physical and Mathematical Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, SingaporeSchool of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, N1.2–B1-14, Singapore 637459, SingaporeSchool of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, N1.2–B1-14, Singapore 637459, SingaporeSchool of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, N1.2–B1-14, Singapore 637459, SingaporeSchool of Physical and Mathematical Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, SingaporeSchool of Chemical and Biomedical Engineering, Nanyang Technological University, 62 Nanyang Drive, N1.2–B1-14, Singapore 637459, SingaporeCinnamoyl sucrose esters (CSEs) were evaluated as AGIs and their enzyme inhibition activity and potency were compared with gold standard acarbose. The inhibition activity of the CSEs against α-glucosidase and α-amylase depended on their structure including the number of the cinnamoyl moieties, their position, and the presence or absence of the acetyl moieties. The inhibitory values of the CSEs <b>2</b>–<b>9</b> generally increases in the order of mono-cinnamoyl moieties < di-cinnamoyl ≤ tri-cinnamoyl < tetra-cinnamoyl. This trend was supported from both in vitro and in silico results. Both tetra-cinnamoyl CSEs <b>5</b> and <b>9</b> showed the highest α-glucosidase inhibitory activities of 77 ± 5%, 74 ± 9%, respectively, against acarbose at 27 ± 4%, and highest α-amylase inhibitory activities of 98 ± 2%, 99 ± 1%, respectively, against acarbose at 93 ± 2%. CSEs <b>3</b>, <b>4</b>, <b>6</b>, <b>7</b>, <b>8</b> showed desired higher inhibition of α-glucosidase than α-amylase suggesting potential for further development as AGIs with reduced side effects. Molecular docking studies on CSEs <b>5</b> and <b>9</b> attributed the high inhibition of these compounds to multiple π-π interactions and favorable projection of the cinnamoyl moieties (especially O-3 cinnamoyl) in the enzyme pockets. This work proposes CSEs as new AGIs with potentially reduced side effects.https://www.mdpi.com/1420-3049/26/2/469phenylpropanoid sucrose estersglycosidesnatural productsα-glucosidase inhibitionα-amylase inhibitionanti-diabetic
spellingShingle Surabhi Devaraj
Yew Mun Yip
Parthasarathi Panda
Li Lin Ong
Pooi Wen Kathy Wong
Dawei Zhang
Zaher Judeh
Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
Molecules
phenylpropanoid sucrose esters
glycosides
natural products
α-glucosidase inhibition
α-amylase inhibition
anti-diabetic
title Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
title_full Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
title_fullStr Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
title_full_unstemmed Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
title_short Cinnamoyl Sucrose Esters as Alpha Glucosidase Inhibitors for the Treatment of Diabetes
title_sort cinnamoyl sucrose esters as alpha glucosidase inhibitors for the treatment of diabetes
topic phenylpropanoid sucrose esters
glycosides
natural products
α-glucosidase inhibition
α-amylase inhibition
anti-diabetic
url https://www.mdpi.com/1420-3049/26/2/469
work_keys_str_mv AT surabhidevaraj cinnamoylsucroseestersasalphaglucosidaseinhibitorsforthetreatmentofdiabetes
AT yewmunyip cinnamoylsucroseestersasalphaglucosidaseinhibitorsforthetreatmentofdiabetes
AT parthasarathipanda cinnamoylsucroseestersasalphaglucosidaseinhibitorsforthetreatmentofdiabetes
AT lilinong cinnamoylsucroseestersasalphaglucosidaseinhibitorsforthetreatmentofdiabetes
AT pooiwenkathywong cinnamoylsucroseestersasalphaglucosidaseinhibitorsforthetreatmentofdiabetes
AT daweizhang cinnamoylsucroseestersasalphaglucosidaseinhibitorsforthetreatmentofdiabetes
AT zaherjudeh cinnamoylsucroseestersasalphaglucosidaseinhibitorsforthetreatmentofdiabetes